Detection of blaCTX-M beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria;Geni̇şlemi̇ş spektrumlu beta-laktamaz üreten gram-negati̇f bakteri̇lerde blaCTX-M beta-laktamaz genleri̇ni̇n araştirilmasi

Mikrobiyoloji Bulteni

Volumn 44, Issue 2, 2010, Pages 187-196

  Bayraktar, Banu ^a   Toksoy, Buket ^a   Bulut, Emin ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Ctx m enzymes; Enterobacteriaceae; Extended spectrum beta lactamase

Indexed keywords

BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOSYNTHESIS; DRUG EFFECT; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; GENETICS; HUMAN; MICROBIOLOGY;

BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS;

EID: 77952830589     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 667-86.
2. Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M type extended-spectrum beta-lactama-ses. Clin Microbiol Infect 2008; 14: 33-41.
3. Stürenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy and infection control.J Infect 2003; 47: 273-95.
4. Paterson DL. Extended-spectrum beta-lactamases: the European experience. Curr Opin Infect Dis 2001; 14: 697-701.
5. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
6. Galas M, Decousser JW, Breton N, et al. Nationwide study of the prevalence, characteristics and molecular epidemiology of extended-spectrum beta-lactamase producing Enterobacteriaceae in France. Antimicrob Agents Chemother 2008; 52: 786-9.
7. Aktaş Z, Gönüllü N, Schneider I, Bal C, Bauernfeind A. Detection of CTX-M-15 type extended-spectrum be-ta-lactamase in an Escherichia coli strain isolated from urine sample of a hospitalized patient. Mikrobiyol Bui 2005; 39: 421-9.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth Informational Supplement, M100-S18. 2008. CLSI, Wayne, PA.
9. st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
10. Pitout JD, Hamilton N, Church DL, Nordmann P, Poirel L. Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type beta-lactamases in Enterobacteriaceae. Clin Microbiol Infect 2007; 13: 291-7.
11. Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase producing organisms. J Hosp Infect 2009; 73: 345-54.
12. Denton M. Enterobacteriaceae. Int J Antimicrob Agent 2007; 29: 9-22.
13. th ed. Springer US, New York.
14. Esen Ş. GSBL ve IBL yapan enterik bakteriler: klinik önemi, tedavi. ANKEM 2008; 22: 28-35.
15. Cantón R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006; 9: 466-75.
16. Mesco Meglic KM, Koren S, Palepou MF, et al. Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals. Antimicrob Agents Chemother 2009; 53: 287-91.
17. Pitout JD, Le P, Church DL, Gregson DB, Laupland KB. Antimicrobial susceptibility of well-characterised mul-tiresistant CTX-M-producing Escherichia coir, failure of automated systems to detect resistance to piperacil-lin/ tazobactam. Int J Antimicrob Agent 2008; 32: 333-8.
18. Gönüllü N, Aktaş Z, Bal Kayacan Ç, et al. Dissemination of CTX-M-15 beta-lactamase genes earned on Inc FI and FII plasmids among clinical isolates of Escherichia coli in a university hospital in Istanbul, Turkey. J Clin Microbiol 2008; 46: 1110-2.
19. Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP. Turkey: a further country concerned by community-acquired Escherichia coli clone 025-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 62: 284-8.
20. th ed. Springer US, New York.
21. Eckert C, Gautier V, Salladin-Allard M, et al. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother 2004; 48:1249-55.
22. Cheng J, Gao W, Yin J, et al. Phenotypic and molecular characterization of two novel CTX-M enzymes carried by Klebsiella pneumoniae. Mol Biol Reports 2009; 36: 423-622.
23. Hawkey PM, Munday CJ. Multiple resistance in gram-negative bacteria. Rev Med Microbiol 2004; 15: 51 -61.
24. Wang Q, Cheng J, Chen Y, Ye Y, Li JB, Zhang XJ. Characterization of a novel AmpC-type plasmid-mediated beta-lactamase from Escherichia coli strain isolated in China. Curr Microbiol 2008; 57: 558-63.
25. Fenollar-Ferrer C, Frau J, Donoso J, Munoz F. Evolution of class C beta-lactamases: factors influencing their hydrolysis and recognition mechanisms. Theor Chem Account 2008; 121: 209-18.
26. Choi SH, Lee JE, Park SJ, et al. Prevalence, microbiology, and clinical characteristics of extended-spectrum beta-lactamase-producing Enterobacter spp., Serratia marcescens, Gtrobacter freundii and Morganella morganii. Eur J Clin Microbiol Infect Dis 2007; 26: 557-61.
27. Shahid M, Ensor VM, Hawkey PM. Emergence and dissemination of Enterobacteriaceae with plasmid-medi-ated CMY-6 and CTX-M-15 beta-lactamases in community in North India. World J Microbial Biotechnol 2009; 25: 1439-46.